250 related articles for article (PubMed ID: 37074076)
1. The clinical and experimental treatment of Juvenile Idiopathic Arthritis.
Nijhuis L; Swart JF; Prakken BJ; van Loosdregt J; Vastert SJ
Clin Exp Immunol; 2023 Oct; 213(3):276-287. PubMed ID: 37074076
[TBL] [Abstract][Full Text] [Related]
2. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.
Ombrello MJ; Arthur VL; Remmers EF; Hinks A; Tachmazidou I; Grom AA; Foell D; Martini A; Gattorno M; Özen S; Prahalad S; Zeft AS; Bohnsack JF; Ilowite NT; Mellins ED; Russo R; Len C; Hilario MO; Oliveira S; Yeung RS; Rosenberg AM; Wedderburn LR; Anton J; Haas JP; Rosen-Wolff A; Minden K; Tenbrock K; Demirkaya E; Cobb J; Baskin E; Signa S; Shuldiner E; Duerr RH; Achkar JP; Kamboh MI; Kaufman KM; Kottyan LC; Pinto D; Scherer SW; Alarcón-Riquelme ME; Docampo E; Estivill X; Gül A; ; Langefeld CD; Thompson S; Zeggini E; Kastner DL; Woo P; Thomson W
Ann Rheum Dis; 2017 May; 76(5):906-913. PubMed ID: 27927641
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease.
Brown RA; Henderlight M; Do T; Yasin S; Grom AA; DeLay M; Thornton S; Schulert GS
Front Immunol; 2018; 9():2995. PubMed ID: 30619348
[No Abstract] [Full Text] [Related]
4. Systemic juvenile idiopathic arthritis versus adult-onset Still´s disease: the pertinence of changing the current classification criteria.
Silva JR; Brito I
Acta Reumatol Port; 2020; 45(2):150-151. PubMed ID: 32895357
[TBL] [Abstract][Full Text] [Related]
5. Patients with Systemic Juvenile Idiopathic Arthritis (SJIA) Show Differences in Autoantibody Signatures Based on Disease Activity.
Krainer J; Hendling M; Siebenhandl S; Fuehner S; Kessel C; Verweyen E; Vierlinger K; Foell D; Schönthaler S; Weinhäusel A
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759792
[TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis.
Lin YT; Wang CT; Gershwin ME; Chiang BL
Autoimmun Rev; 2011 Jun; 10(8):482-9. PubMed ID: 21320644
[TBL] [Abstract][Full Text] [Related]
7. Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis.
Ling XB; Macaubas C; Alexander HC; Wen Q; Chen E; Peng S; Sun Y; Deshpande C; Pan KH; Lin R; Lih CJ; Chang SY; Lee T; Sandborg C; Begovich AB; Cohen SN; Mellins ED
BMC Med; 2012 Oct; 10():125. PubMed ID: 23092393
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in our understanding of the pathogenesis of juvenile idiopathic arthritis and their potential clinical implications.
Leong JY; Guan YJ; Albani S; Arkachaisri T
Expert Rev Clin Immunol; 2018 Nov; 14(11):933-944. PubMed ID: 30269617
[TBL] [Abstract][Full Text] [Related]
9. Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.
Chen G; Deutsch GH; Schulert GS; Zheng H; Jang S; Trapnell B; Lee PY; Macaubas C; Ho K; Schneider C; Saper VE; de Jesus AA; Krasnow MA; Grom A; Goldbach-Mansky R; Khatri P; Mellins ED; Canna SW
Arthritis Rheumatol; 2022 Jul; 74(7):1271-1283. PubMed ID: 35189047
[TBL] [Abstract][Full Text] [Related]
10. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives.
Ambler WG; Nanda K; Onel KB; Shenoi S
Ann Med; 2022 Dec; 54(1):1839-1850. PubMed ID: 35786149
[TBL] [Abstract][Full Text] [Related]
11. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis.
Hügle B; Schippers A; Fischer N; Ohl K; Denecke B; Ticconi F; Vastert B; Costa IG; Haas JP; Tenbrock K
Arthritis Res Ther; 2018 May; 20(1):98. PubMed ID: 29848367
[TBL] [Abstract][Full Text] [Related]
13. Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states.
Macaubas C; Nguyen K; Deshpande C; Phillips C; Peck A; Lee T; Park JL; Sandborg C; Mellins ED
Clin Immunol; 2010 Feb; 134(2):206-16. PubMed ID: 19879195
[TBL] [Abstract][Full Text] [Related]
14. Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.
Schulert GS; Yasin S; Carey B; Chalk C; Do T; Schapiro AH; Husami A; Watts A; Brunner HI; Huggins J; Mellins ED; Morgan EM; Ting T; Trapnell BC; Wikenheiser-Brokamp KA; Towe C; Grom AA
Arthritis Rheumatol; 2019 Nov; 71(11):1943-1954. PubMed ID: 31379071
[TBL] [Abstract][Full Text] [Related]
15. The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis.
Aljaberi N; Tronconi E; Schulert G; Grom AA; Lovell DJ; Huggins JL; Henrickson M; Brunner HI
Pediatr Rheumatol Online J; 2020 Jan; 18(1):7. PubMed ID: 31948488
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
Ruperto N; Brunner HI; Ramanan AV; Horneff G; Cuttica R; Henrickson M; Anton J; Boteanu AL; Penades IC; Minden K; Schmeling H; Hufnagel M; Weiss JE; Pardeo M; Nanda K; Roth J; Rubio-Pérez N; Hsu JC; Wimalasundera S; Wells C; Bharucha K; Douglass W; Bao M; Mallalieu NL; Martini A; Lovell D; Benedetti F;
Rheumatology (Oxford); 2021 Oct; 60(10):4568-4580. PubMed ID: 33506875
[TBL] [Abstract][Full Text] [Related]
17. Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.
Hinze CH; Holzinger D; Lainka E; Haas JP; Speth F; Kallinich T; Rieber N; Hufnagel M; Jansson AF; Hedrich C; Winowski H; Berger T; Foeldvari I; Ganser G; Hospach A; Huppertz HI; Mönkemöller K; Neudorf U; Weißbarth-Riedel E; Wittkowski H; Horneff G; Foell D;
Pediatr Rheumatol Online J; 2018 Jan; 16(1):7. PubMed ID: 29357887
[TBL] [Abstract][Full Text] [Related]
18. Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis.
Gohar F; McArdle A; Jones M; Callan N; Hernandez B; Kessel C; Miranda-Garcia M; Lavric M; Holzinger D; Pretzer C; Lainka E; Vastert SJ; de Roock S; FitzGerald O; Pennington SR; Foell D
Ann Rheum Dis; 2019 Aug; 78(8):1107-1113. PubMed ID: 31005900
[TBL] [Abstract][Full Text] [Related]
19. Is Still's Disease an Autoinflammatory Syndrome?
Rossi-Semerano L; Koné-Paut I
Int J Inflam; 2012; 2012():480373. PubMed ID: 22611516
[TBL] [Abstract][Full Text] [Related]
20. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.
Hügle B; Hinze C; Lainka E; Fischer N; Haas JP
Pediatr Rheumatol Online J; 2014; 12():28. PubMed ID: 25114627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
